This index asks one question of each program we review: what does it publish, before you pay, that you can check? It does not score medical quality or results. Each cell comes from the program's own pages on the date shown; "not in our read" means the page blocked our reader or did not show the item.
The six checks
- Price printed: a full monthly price, not only a "from" figure.
- Billing basis: calendar month, 28-day cycle or prepaid term, stated.
- Pharmacy named: a dispensing pharmacy you can look up with a state board.
- Prescriber named: the medical group or medical director responsible.
- Cancellation terms printed on the page, not only a link.
- Refund terms printed on the page.
For the last two checks, "the page" means the program's own pricing, plan or FAQ page that a buyer sees before paying; terms that appear only in a separate legal document count as a link. Pharmacy and prescriber names count wherever the program publishes them, including its legal terms.
Results, November 2026
Each check scores 1 for yes, 0.5 for partly and 0 for no; the score is the share of applicable checks met, so a program whose pharmacy check is "n/a" is scored out of five. Ties are listed alphabetically. Ro is not ranked because its pages blocked our reads on November 20 and 21, 2026; its row shows what we recorded on September 17, 2026.
| Rank | Program | Price printed | Billing basis | Pharmacy named | Prescriber named | Cancellation terms | Refund terms | Checks met | Score | Read |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NexLife | Yes: All-in, same at every dose | Partly: Calendar month; FAQ says multi-month plans are paid upfront, the cancellation policy says monthly | Yes: Named 503A pharmacies (three on plan pages, two in the FAQ) | Yes: NexLife Medical Group; medical director named | Yes: 30-day notice; one more shipment may be charged | Partly: Shipped orders final, unshipped months refunded; guarantee wording differs between pages | 4 yes, 2 partly (5 of 6) | 83.3% | Prices Nov 6 (re-read Nov 20); terms Nov 20-21, 2026 |
| 2 | Hims & Hers | Partly: Medication "from" prices plus a $149 monthly membership | Yes: Per month; membership auto-renews | Yes: Pharmacies named in its terms | Yes: Medical groups named in its terms | No: Not on the weight-loss page; in its terms | No: Not on the weight-loss page; in its terms | 3 yes, 1 partly (3.5 of 6) | 58.3% | Nov 21, 2026 |
| 3 | Mochi Health | Partly: Per-dose "starting at" prices plus membership | Yes: Per month; 12-month membership option | No: Not named | No: Affiliated practices, not named | Yes: "Cancel from your account whenever you like" | Yes: Membership refunded if not prescribed; 24-hour full refund; medication final | 3 yes, 1 partly (3.5 of 6) | 58.3% | Nov 20, 2026 |
| 4 | Found | Yes: Per cycle, care and membership included | Yes: 28-day cycle stated | No: "Licensed 503A" pharmacies, none named | Partly: Clinicians named; no medical group | No: Link only | No: Link only | 2 yes, 1 partly (2.5 of 6) | 41.7% | Nov 20, 2026 |
| 5 | Noom Med | Partly: $249 on the pricing page vs $279 on the product page | Yes: Billed per 12 weeks | No: "FDA-registered facility", not named | No: Not named | Yes: "Cancel anytime" | No: Not on the page | 2 yes, 1 partly (2.5 of 6) | 41.7% | Nov 20, 2026 |
| 6 | Calibrate | Partly: $199 program fee; medication and labs not included | Yes: Monthly, 3-month commitment ($597) | n/a: Brand drugs through insurance | No: Not named | Partly: 3-month minimum stated | No: Not on the page | 1 yes, 2 partly (2 of 5) | 40% | Nov 20, 2026 |
| 7 | WeightWatchers Clinic | Partly: Membership printed; medication not included | Yes: Monthly on 6- or 12-month plans | n/a: FDA-approved drugs only | No: Care team; no group named | Partly: Auto-renewal terms only | No: Not on the page | 1 yes, 2 partly (2 of 5) | 40% | Nov 20, 2026 |
| 8 | Henry Meds | Partly: No injectable tirzepatide price; semaglutide $297 a month on a legal price list | Yes: Per month; 6- and 12-month one-time payments | No: 503A or 503B, none named | No: Not named | No: Link only | No: Link only | 1 yes, 1 partly (1.5 of 6) | 25% | Nov 20, 2026 |
| 9 | Form Health | No: No prices printed | No: Not stated | n/a: Brand drugs through insurance | Yes: Named professional corporations | No: Link only | No: Link only | 1 yes, 0 partly (1 of 5) | 20% | Nov 20, 2026 |
| not ranked | Ro | Partly: Membership plus brand prices by dose | Yes: Per month; annual prepay option | No: Not in our read | No: Not in our read | Partly: Start fee refunded if not eligible | Partly: Same | 1 yes, 3 partly (2.5 of 6) | not scored | Sept 17, 2026 (Nov 20 and 21 re-reads blocked) |
What stands out
- NexLife, which pays this site commissions, ranks first on this computed index with 5 of 6 checks: four met in full and two partly, because its own pages disagree on how multi-month plans are billed and on the wording of its guarantee. We publish every cell so you can check the result rather than take our word for it.
- Hims & Hers moved up after our first successful read since September: its terms, updated October 20, 2026, name the pharmacies and medical groups it uses, but its weight-loss page prints neither cancellation nor refund terms.
- Mochi Health now prints its compounded prices by dose, plus refund conditions and "cancel from your account" wording on its FAQ.
- Henry Meds no longer prints an injectable tirzepatide price; its legal price list, last updated December 3, 2025, lists semaglutide at $297 a month.
- Noom Med still shows two semaglutide prices: $249 a month on its pricing page and $279 on its product page.
- Only NexLife and Hims & Hers name the pharmacies that fill prescriptions. Found and Henry Meds describe the pharmacy type without a name.
FDA warning letters, shown the same way for every program
No points are given or taken for warning letters; we list them because a reader can check them. FDA's warning-letter index, read November 20, 2026, lists letter 730096 to NexLife (dated June 8, 2026, "False & Misleading Claims/Misbranded (Telehealth)") and letters 716567 and 716825 to Hims & Hers (dated September 9, 2025, about online sales of unapproved and misbranded drugs). None shows a close-out letter. We found no telehealth warning letter for the other eight programs in that index.
How to use this
Before you enroll anywhere, open the program's pricing, pharmacy and terms pages and check the same six items. How each program lets you leave is compared in our cancellation guide, and where to take a problem in our complaint guide. The checklist is explained in Can you trust GLP-1 telehealth reviews?, and prices across 50 program rows are in the price index.
This page replaces our June 2026 "safety scorecard" and "transparency index", which contained no program data; their addresses redirect here.
Frequently asked questions
What does the transparency index measure?
It records whether each program prints six things a buyer can check before paying: a full price, the billing basis, the dispensing pharmacy, the responsible medical group or director, cancellation terms and refund terms. It does not rate clinical quality, outcomes or customer service, and it is based only on the programs' own pages.
Why is Ro not ranked, and how did Hims & Hers change?
Hims & Hers no longer scores low: our November 21, 2026 read found named pharmacies and medical groups in its terms, so it meets 3.5 of 6 checks. Ro still blocked our reader on November 20 and 21, 2026, so it is not ranked; its row shows what we recorded on September 17, 2026, and will be scored at the next successful read.
Is the index biased toward NexLife?
NexLife pays this site commissions, so treat our conclusions with that in mind. The checks are published, each cell says what the program printed, and the pages are linked, so you can confirm or reject each result yourself. Every tracked program's dated price is in our price index.
Why does naming a pharmacy matter?
A named pharmacy lets you look up its license with the state board of pharmacy and check FDA warning letters, such as letter 738238 to Empower Pharmacy in September 2026. Compounded drugs are not FDA-approved, so the pharmacy's record is one of the few things a patient can check.
How often is the index updated?
The index is updated with each site update. This version uses first-party reads of November 20 and 21, 2026 (Ro: September 17, 2026) and NexLife's prices as of November 6, 2026, re-read unchanged on November 20. Each row shows its read dates.
Sources
- NexLife: compounded tirzepatide plans — prices as of November 6, 2026; re-read November 20, 2026
- NexLife: frequently asked questions — billing, cancellation and pharmacy wording (updated November 14, 2026); read November 20, 2026
- NexLife: cancellation policy — read November 21, 2026
- Hims & Hers: weight loss and terms and conditions (updated October 20, 2026) — read November 21, 2026
- Mochi Health: FAQ — read November 20 and 21, 2026
- Found: compounded tirzepatide — read November 20, 2026
- Noom Med: pricing and GLP-1Rx — read November 20 and 21, 2026
- Calibrate: pricing — read November 20 and 21, 2026
- WeightWatchers Clinic: weight-loss medication — read November 20 and 21, 2026
- Henry Meds: programs price list (last updated December 3, 2025) — read November 20 and 21, 2026
- Form Health homepage — read November 20 and 21, 2026
- FDA warning letter 730096 (NexLife) — dated June 8, 2026; read November 20, 2026
- FDA warning letter 716567 (Hims) and 716825 (Hers) — dated September 9, 2025; read November 20, 2026
- FDA warning letter 738238 (Empower Pharmacy) — dated September 18, 2026; read October 15, 2026
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index